General MedicationsORALGeneric
SPECTROBID
BACAMPICILLIN HYDROCHLORIDE
Standard Dose
400MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview SPECTROBID is listed in Drugs@FDA under application 050520 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient BACAMPICILLIN HYDROCHLORIDE Form and strength TABLET;ORAL - 400MG Sponsor PFIZER Submission history Latest submission status date: 1992-05-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview SPECTROBID is listed in Drugs@FDA under application 050520 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BACAMPICILLIN HYDROCHLORIDE Form and strength TABLET;ORAL - 400MG Sponsor PFIZER Submission history Latest submission status date: 1992-05-29 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.